Global Left Ventricular Assist Device (LVAD) Market Forecast to 2022

Infinium Global Research has added a new report on Global Left Ventricular Assist Device (LVAD) Market. The report predicts the market size of Left Ventricular Assist Device (LVAD) is expected to reach XX billion by 2022

The report covers the analysis of Left Ventricular Assist Device (LVAD). Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.

Some of the key driving factors attributing to the growth of this include increasing number of patients with cardiovascular diseases such as hypertension, heart failures and coronary artery diseases, and shortage of number of heart donors. In addition, changing lifestyle, alcohol consumption, growing obesity and smoking further propelling the market growth, as these factors increase the bold glucose and lipid levels, which results in serious cardiovascular diseases. According to American Heart Association publication, it has been estimated that in the US alone approximately 5.5 million people suffered from heart failure in 2013 and 300,000 die each year because of heart failure. The market for LVAD is expected to reach around USD 1.9 billion by 2022, growing at a CAGR of 17.3% during the forecast period of 2016 to 2022. However, there are certain restraining factors which could hamper the growth of the market, which includes, high costs associated with the LAVD implantation compared to other therapies available for CVD diseases.

Companies profiled:

  • Abiomed
  • Heart Ware International Inc.
  • St Jude Medical
  • Berlin Heart GmbH
  • Apaxis, Inc.
  • Jarvik Heart Inc.

Key Topics Covered:

  • 1.Scope of the report
  • 2.Executive summary
  • 3.Qualitative analysis
  • 4.lobal LVAD market, by type of indication, 2014 – 2022
  • 5.Global LVAD market, by geography, 2014 – 2022
  • 6.Company profiles

Click below to access full report @

%d bloggers like this: